---
schema_version: "secwatch.filing_event.v1"
accession: "0001520138-22-000583"
form_type: "8-K"
ticker: "BIVI"
cik: "0001580149"
company_name: "BIOVIE INC."
filed_at: "2022-12-23T23:59:59+00:00"
generated_at: "2026-06-20T23:20:53.401026+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# BioVie files prospectus supplement for $17.5M ATM offering; already raised $29M

## Summary
- Filed prospectus supplement on Dec 23, 2022 for up to $17.5M in Class A common stock sales.
- As of Dec 20, 2022, issued 3,709,509 shares under existing ATM for net proceeds of $29.0M.
- Sales agents are Cantor Fitzgerald & Co. and B. Riley Securities, Inc.
- New shares offered under Registration Statement No. 333-252386 via the August 31, 2022 Sales Agreement.

## SEC filing metadata
- accession: 0001520138-22-000583
- form_type: 8-K
- ticker: BIVI
- cik: 0001580149
- company_name: BIOVIE INC.
- filed_at: 2022-12-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1580149/000152013822000583/0001520138-22-000583-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1580149/000152013822000583/bivi-20221223_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001520138-22-000583
- JSON: https://secwatch.observer/filing/0001520138-22-000583.json
- Plain text: https://secwatch.observer/filing/0001520138-22-000583.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.